104 related articles for article (PubMed ID: 12821717)
21. Inflammatory cytokines activate p38 MAPK to induce osteoprotegerin synthesis by MG-63 cells.
Pantouli E; Boehm MM; Koka S
Biochem Biophys Res Commun; 2005 Apr; 329(1):224-9. PubMed ID: 15721297
[TBL] [Abstract][Full Text] [Related]
22. Serine/threonine kinase, Cot/Tpl2, regulates renal cell apoptosis in ischaemia/reperfusion injury.
Yaomura T; Tsuboi N; Urahama Y; Hobo A; Sugimoto K; Miyoshi J; Matsuguchi T; Reiji K; Matsuo S; Yuzawa Y
Nephrology (Carlton); 2008 Oct; 13(5):397-404. PubMed ID: 18518937
[TBL] [Abstract][Full Text] [Related]
23. Expression of osteoprotegerin and RANK ligand in breast cancer bone metastasis.
Park HR; Min SK; Cho HD; Kim DH; Shin HS; Park YE
J Korean Med Sci; 2003 Aug; 18(4):541-6. PubMed ID: 12923331
[TBL] [Abstract][Full Text] [Related]
24. Oral squamous cell carcinoma cells induce osteoclast differentiation by suppression of osteoprotegerin expression in osteoblasts.
Tada T; Jimi E; Okamoto M; Ozeki S; Okabe K
Int J Cancer; 2005 Aug; 116(2):253-62. PubMed ID: 15800904
[TBL] [Abstract][Full Text] [Related]
25. Breast cancer cells interact with osteoblasts to support osteoclast formation.
Thomas RJ; Guise TA; Yin JJ; Elliott J; Horwood NJ; Martin TJ; Gillespie MT
Endocrinology; 1999 Oct; 140(10):4451-8. PubMed ID: 10499498
[TBL] [Abstract][Full Text] [Related]
26. Fluid flow induces Rankl expression in primary murine calvarial osteoblasts.
Mehrotra M; Saegusa M; Wadhwa S; Voznesensky O; Peterson D; Pilbeam C
J Cell Biochem; 2006 Aug; 98(5):1271-83. PubMed ID: 16514640
[TBL] [Abstract][Full Text] [Related]
27. A serine/threonine kinase, Cot/Tpl2, modulates bacterial DNA-induced IL-12 production and Th cell differentiation.
Sugimoto K; Ohata M; Miyoshi J; Ishizaki H; Tsuboi N; Masuda A; Yoshikai Y; Takamoto M; Sugane K; Matsuo S; Shimada Y; Matsuguchi T
J Clin Invest; 2004 Sep; 114(6):857-66. PubMed ID: 15372110
[TBL] [Abstract][Full Text] [Related]
28. Tpl2 transduces CD40 and TNF signals that activate ERK and regulates IgE induction by CD40.
Eliopoulos AG; Wang CC; Dumitru CD; Tsichlis PN
EMBO J; 2003 Aug; 22(15):3855-64. PubMed ID: 12881420
[TBL] [Abstract][Full Text] [Related]
29. Functional roles of Cot/Tpl2 in mast cell responses to lipopolysaccharide and FcεRI-clustering.
Chiba N; Kakimoto K; Masuda A; Matsuguchi T
Biochem Biophys Res Commun; 2010 Nov; 402(1):1-6. PubMed ID: 20732300
[TBL] [Abstract][Full Text] [Related]
30. CTRP3 acts as a negative regulator of osteoclastogenesis through AMPK-c-Fos-NFATc1 signaling in vitro and RANKL-induced calvarial bone destruction in vivo.
Kim JY; Min JY; Baek JM; Ahn SJ; Jun HY; Yoon KH; Choi MK; Lee MS; Oh J
Bone; 2015 Oct; 79():242-51. PubMed ID: 26103094
[TBL] [Abstract][Full Text] [Related]
31. Age of donor alters the effect of cyclic hydrostatic pressure on production by human macrophages and osteoblasts of sRANKL, OPG and RANK.
Evans CE; Mylchreest S; Andrew JG
BMC Musculoskelet Disord; 2006 Mar; 7():21. PubMed ID: 16519799
[TBL] [Abstract][Full Text] [Related]
32. Fibroblastic stromal cells express receptor activator of NF-kappa B ligand and support osteoclast differentiation.
Quinn JM; Horwood NJ; Elliott J; Gillespie MT; Martin TJ
J Bone Miner Res; 2000 Aug; 15(8):1459-66. PubMed ID: 10934644
[TBL] [Abstract][Full Text] [Related]
33. [Ascorbic acid inhibits the formation and function of osteoclasts from RAW264.7 cells induced by receptor activated nuclear factor kappaB ligand in vitro].
Xiao XH; Zhou HD; Yuan LQ; Xie H; Liao EY
Zhonghua Yi Xue Za Zhi; 2004 Dec; 84(24):2102-6. PubMed ID: 15730627
[TBL] [Abstract][Full Text] [Related]
34. Androgens suppress osteoclast formation induced by RANKL and macrophage-colony stimulating factor.
Huber DM; Bendixen AC; Pathrose P; Srivastava S; Dienger KM; Shevde NK; Pike JW
Endocrinology; 2001 Sep; 142(9):3800-8. PubMed ID: 11517156
[TBL] [Abstract][Full Text] [Related]
35. Adenosine triphosphate stimulates human osteoclast activity via upregulation of osteoblast-expressed receptor activator of nuclear factor-kappa B ligand.
Buckley KA; Hipskind RA; Gartland A; Bowler WB; Gallagher JA
Bone; 2002 Nov; 31(5):582-90. PubMed ID: 12477572
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of osteoclast differentiation and bone resorption by tanshinone IIA isolated from Salvia miltiorrhiza Bunge.
Kim HH; Kim JH; Kwak HB; Huang H; Han SH; Ha H; Lee SW; Woo ER; Lee ZH
Biochem Pharmacol; 2004 May; 67(9):1647-56. PubMed ID: 15081864
[TBL] [Abstract][Full Text] [Related]
37. Phosphorylation of TPL-2 on serine 400 is essential for lipopolysaccharide activation of extracellular signal-regulated kinase in macrophages.
Robinson MJ; Beinke S; Kouroumalis A; Tsichlis PN; Ley SC
Mol Cell Biol; 2007 Nov; 27(21):7355-64. PubMed ID: 17709378
[TBL] [Abstract][Full Text] [Related]
38. Dual modulation of osteoclast differentiation by lipopolysaccharide.
Zou W; Bar-Shavit Z
J Bone Miner Res; 2002 Jul; 17(7):1211-8. PubMed ID: 12096834
[TBL] [Abstract][Full Text] [Related]
39. Icariin inhibits osteoclast differentiation and bone resorption by suppression of MAPKs/NF-κB regulated HIF-1α and PGE(2) synthesis.
Hsieh TP; Sheu SY; Sun JS; Chen MH
Phytomedicine; 2011 Jan; 18(2-3):176-85. PubMed ID: 20554188
[TBL] [Abstract][Full Text] [Related]
40. Cot/Tpl2 regulates IL-23 p19 expression in LPS-stimulated macrophages through ERK activation.
Kakimoto K; Musikacharoen T; Chiba N; Bandow K; Ohnishi T; Matsuguchi T
J Physiol Biochem; 2010 Mar; 66(1):47-53. PubMed ID: 20405269
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
